Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Terrana Biosciences raised $50M in a Series A funding from Flagship Pioneering to scale operations and develop its RNA-based agricultural solutions.
PRIVATEJul 03, 2025•about 1 year ago
Amount Raised
$50 Million
Round Type
Series A
CambridgeBiotechnology
Investors
Flagship Pioneering
Description
Terrana Biosciences, a Cambridge, MA-based company providing RNA-based agricultural solutions, received $50M from Flagship Pioneering. The company intends to use the funds to scale operations and develop its first products in crop protection and yield. Led by co-CEOs Noubar Afeyan and Ryan Rapp, Terrana combines RNA technology with advanced computational biology. They have created a pipeline of 15+ potential products in specialty and row crops.
Company Information
Company
Terrana Biosciences
Location
Cambridge, Massachusetts, United States
About
Terrana’s novel technology platform enables resilient agriculture for a rapidly changing world through RNA-based plant health solutions. Our technology opens the door to endowing crops with any desired trait without altering the plant genome and delivering solutions with unmatched flexibility, precision, and speed that can be applied at any point in a plant’s lifecycle.
Predictive Intelligence
Strategic
ML-powered predictions for Terrana Biosciences's next move
CambridgeBiotechnology